Menu Close
The Conversation

Kristie Bloom

1

Article

0

Comments
Group Leader: Next-generation Vaccines, Antiviral Gene Therapy Research Unit, University of the Witwatersrand

Kristie Bloom completed her PhD at AGTRU in 2013 where she developed genome engineering agents to permanently disable HBV. As a post-doctoral researcher at the Uniklinik Freiburg, Germany, she investigated stem cell gene therapy approaches for the treatment of paediatric immunodeficiencies. Since re-joining AGTRU, her research has focused on developing anti-HBV gene therapies and mRNA vaccines for infectious diseases.

Experience

  • –present
    Group Leader: Next-generation Vaccines, Antiviral Gene Therapy Research Unit, University of the Witwatersrand